Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$55.27
-0.1-0.18%
Last update: Oct 12, 5:10 PM
$54.94
-0.43-0.78%
TG Therapeutics Inc (TGTX) Stock Price, Quote, News & History
TGTXNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on acquiring, developing, and commercializing novel treatments for B-cell diseases. In addition to a research pipeline, TG Therapeutics has received approval...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of TG Therapeutics (NASDAQ:TGTX) through any online brokerage.
Other companies in TG Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
TG Therapeutics has a consensus price target of $51.45.
The stock price for TG Therapeutics (NASDAQ: TGTX) is $54.9363 last updated October 12, 2026 at 5:10 PM EDT.
There are no upcoming dividends for TG Therapeutics.
TG Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for TG Therapeutics.
TG Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
